Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.

@article{Pilotto2000PantoprazoleVO,
  title={Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.},
  author={Alberto Pilotto and Francesco Di Mario and Marilisa Franceschi and Gioacchino Leandro and Giuseppe Battaglia and Bastianello German{\`a} and Renato Marin and Gianni Valerio},
  journal={Alimentary pharmacology & therapeutics},
  year={2000},
  volume={14 8},
  pages={1077-82}
}
AIM To compare the efficacy of pantoprazole vs. a one-week Helicobacter pylori eradication therapy for the prevention of NSAID-related gastroduodenal damage. METHODS Patients over 60 years old with symptoms and/or a history of ulcer who needed NSAID treatment were evaluated by endoscopy. H. pylori positive subjects who had no severe gastroduodenal lesions were randomized to take, concomitantly with NSAID therapy, either: (i) pantoprazole 40 mg daily plus amoxycillin 1 g b.d. and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use: eradication, acid-reducing therapy, or both?

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2012

Similar Papers

Loading similar papers…